Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotechnologies and liver diseases.

S Sherlock1

  • 1Department of Surgery, Royal Free Hospital School of Medicine, London.

Forum (Genoa, Italy)
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Viral hepatitis poses a significant European health challenge. Economic evaluations of hepatitis A and B vaccines are discussed, alongside the critical need for hepatitis C vaccines and improved treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.

Clinics in liver disease·2001
Same author

A la carte interferon for hepatitis C?

Hepatology (Baltimore, Md.)·2000
Same author

The hepatic flaviviridae: summary.

Journal of viral hepatitis·2000
Same author

Carbon dioxide embolism following diagnostic hysteroscopy.

Anaesthesia and intensive care·1999
Same author

Focal nodular hyperplasia in a young female.

Journal of hepatology·1999
Same author

Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity?

Mayo Clinic proceedings·1998

Area of Science:

  • Public Health
  • Virology
  • Hepatology

Background:

  • Viral hepatitis represents a substantial public health concern across Europe.
  • Current vaccination strategies and antiviral therapies for hepatitis B and C are discussed.
  • The limitations of liver transplantation and artificial liver support are highlighted.

Purpose of the Study:

  • To survey viral hepatitis as a European problem.
  • To discuss the economic implications of hepatitis A and B vaccination programs.
  • To emphasize the need for hepatitis C vaccines and improved treatments.

Main Methods:

  • Economic analysis of vaccination programs.
  • Review of current antiviral therapies.
  • Discussion of liver transplantation and artificial liver support limitations.

Related Experiment Videos

Main Results:

  • Vaccination against hepatitis A and B has significant economic implications for infant and adolescent programs.
  • Antiviral therapy for hepatitis B and C remains unsatisfactory.
  • Donor shortage limits liver transplantation, necessitating research into artificial liver support.

Conclusions:

  • There is an urgent need for a hepatitis C vaccine.
  • Current antiviral treatments for hepatitis B and C are inadequate.
  • Increased research into artificial liver support methods is crucial due to donor shortages for liver transplantation.